Table 2. Efficacy results: objective response rates by WHO criteria and secondary tumour resection (intention-to-treat analysis).
| RT-5-FU (n=31) | RT-GC (n=32) | RT-GC+GC (n=31) | |
|---|---|---|---|
| No. (%) | No. (%) | No. (%) | |
| Response | |||
| Complete response | 0 (0) | 2 (6) | 0 (0) |
| Partial response | 6 (19) | 5 (16) | 4 (13) |
| Stable disease | 5 (16) | 11 (34) | 10 (32) |
| Disease control ratea | 11 (35) | 18 (56) | 14 (45) |
| Progressive disease | 12 (39) | 9 (28) | 6 (19) |
| Not assessable | 8 (26) | 5 (16) | 11 (35) |
| Secondary resection | |||
| Yes | 4 (13) | 8 (25) | 6 (19) |
| No | 27 (87) | 24 (75) | 25 (81) |
Abbreviations: 5-FU=5-fluorouracil; C=cisplatin; G=gemcitabine; RT=radiotherapy.
a
Disease control rate=rate of complete response+partial response+stable disease.